Peer Review History
| Original SubmissionSeptember 12, 2019 |
|---|
|
PONE-D-19-25644 Oral ascorbic acid 2-glucoside prevents coordination disorder induced by blast-related mild traumatic brain injury in a rat model PLOS ONE Dear Dr Maekawa, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers feel that your study is sound and that your data support your conclusions, but the second review made some important recommendations that I agree would strengthen this submission significantly, We would appreciate receiving your revised manuscript by Jan 05 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Alfred S Lewin, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 'Oral ascorbic acid 2-glucoside prevents coordination disorder induced by blast-related mild traumatic brain injury in a rat model'. This is a well structred and well written manuscript. It is acceptable in its current form. Reviewer #2: Comments Introduction: “Lines 62-65: Notably, most of the bTBI patients lack any external physical evidences and abnormalities detected by conventional imaging devices, but in the chronic phase, they develop persistent physiological and psychological changes associated with higher-order brain dysfunction, which is called blast-related mild TBI (bmTBI) (4, 5).” In reference to this statement, authors should specify that most of the bTBI patients who are exposed to low or mild blast exposure may not show signs of overt pathology in the acute phase. Mild blast should not be confused with mild TBI. Lines 66-70: The cited work primarily evaluated the effects of shock wave (blast overpressure and/or underpressure) on neuropathology, oxidative stress, and the applicability of antioxidants in ameliorating the behavioral deficits. The authors are applying these findings to laser-induced (LISW) brain injury. The authors need to establish the relevance of LISW to blast overpressure. In general, the introduction is too short. I suggest the following: 1) Include literature that compared the common data elements of LISW and blast shock wave. 2) Include literature that shows LISW can have the same effects as IEDs, microexplosions and blast/shock tubes to be able to make a strong case for calling this model of injury a blast model. 3) Cite work from other authors who have shown blast related oxidative stress and inflammation. A single sentence on BBB disruption, inflammation, and edema doesn’t do justice to the body of literature that exists on blast-related neurological deficits. Since the focus is on oxidative stress, the authors can include few sentences on ROS, RNS, free radicals etc. There should be referece to some prior work that shows behavioral/motor deficits after blast. Also ref # 7 focuses on the efficacy of increasing the cerebral volume in being protective against blast-induced TBI. 4) How have antioxidants helped against blast-TBI? Authors have mentioned free radical scavenging. What happens to the endogenous antioxidatve mechanisms after blast exposure(s)? 5) Why AA2G in particular? What preliminary studies or literature supports the use of this particular antioxidant? 6) Why rotarod test in particular? “AA2G (Hayashibara Co., Okayama, Japan) was dissolved in distilled water and was administered daily per os (p.o.) to rats at 250 mg/kg/15mL/day (ascorbic acid: 125 mg/kg/day) after LISW application for a total of 7 days (LISW + post AA2G group).” Did the animals receive ascorbic acid and its derivative (AA2G)? Please clarify the dosage and the daily frequency (once/day?) of what was administered. Animal grouping: The description is a bit confusing. It has been described differently in different parts of the manuscript. Figure 1 is helpful I understanding the grouping. It seems like a total of four animal groups were used, which are: 1) Control, 2) LISW, 3) LISW+pre AA2G, and 4) LISW+pre-and post- AA2G. Figure 1B lists LISW again. Did the experimental design have a total of 20 animals in LISW group (combining Figures 1 A and B)? If so, why? Why was rotarod testing done at 1 day prior to injury in some groups and 3 days prior to injury in other groups? Generation and Characteristics of LISW: The shock wave generated by lasers (Fig 2) lack the underpressure that’s seen in the primary blast wave. It seems the authors are establishing LISW as a model of simulated blast injury. The authors need to provide more details (common data elements) of the pressure profile itself. Figure 2B- What are the characteristics after the 2 microsecond period? Are there any reflections or is it a flat line? Is the aim here to simulate primary blast wave? One has to make a really strong case to compare LISWs to blast explosions- otherwise the title is misleading. The application of the injury is very focal which is in contrast to blast injury (that’s diffused). Simulated blast pressures include static and dynamic pressures, which is lacking in the LISW model of injury. I strongly suggest changing the title of the manuscript to indicate this distinction clear. “Although peak pressures and durations of LISWs are roughly three orders of magnitude higher and three orders of magnitude shorter than those of medically relevant actual explosions, respectively (28), impulse (time-integrated positive pressures) of actual explosions and LISWs used in this study are in the same order.” Please clarify. What blast pressures do they intend to compare the generated LISWs. If the comparison is made with mild blast intensities (10-15 PSI), then an increase by three orders of magnitude in peak intensity would make sense. What are the impulse values of the positive phase of LISW pressure profile? “… impulse (time-integrated positive pressures) of actual explosions and LISWs used in this study are in the same order: The comment on impulse may not be correct. Please provide relevant impulse values from the literature. “The laser spot size and fluence on the target were kept constant at 3 mm and 2.4 J/cm2, respectively, producing an LISW with an impulse of 54 Pa•s.” Please provide more details of the peak, duration, frequency, power, etc? In general, LISW model as presented here may not be comparable to blast explosions. One would err on the side of caution and call this model simply as LISW model instead of clubbing it under blast. There isn’t enough evidence presented in the manuscript to support the author’s claim. Line 155: rpm/min- correct to rpm Statistics: Was the data checked for normal distribution? Results: Figure 3: Why are the sample sizes small? N= 4? With such small sample size, what’s of the power of the design? Is there any explanation for TNF-α being insignificantly different between control and injury groups? Figures 4A and 4B should include the control group as well. It’s been shown that post-LISW administration of AA2G is not beneficial in circumventing the oxidative stress induced by the injury. Pre+post- AA2G administration seems to be beneficial. Is it possible that simply the preemptive treatment with AA2G might be enough to inhibit the progression of oxidative stress? Why haven’t authors chosen to study only the prophylactic properties of the antioxidant? Please provide a justification. Combining the pre-and post- application in the same group of animals doesn’t necessarily rule out the therapeutic properties of AA2G- it suggests a combined prophylactic and therapeutic potential of AA2G. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Pinar Kuru Bektasoglu Reviewer #2: Yes: Usmah Kawoos [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain PONE-D-19-25644R1 Dear Dr. Maekawa, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Alfred S Lewin, Ph.D. Section Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: The authors gave satisfactorily revised the manuscript. Needs minor editorial corrections, but otherwise all comments have been addressed. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Usmah Kawoos |
| Formally Accepted |
|
PONE-D-19-25644R1 Oral ascorbic acid 2-glucoside prevents coordination disorder induced via laser-induced shock waves in rat brain Dear Dr. Maekawa: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Alfred S Lewin Section Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .